{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:00:12Z","timestamp":1793293212968,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.semdp.2025.150946","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:48:00Z","timestamp":1754441280000},"page":"150946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pancreatic neuroendocrine neoplasms: current paradigms and diagnostic challenges"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-6111","authenticated-orcid":false,"given":"Grace J","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-6479","authenticated-orcid":false,"given":"Chanjuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0001","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11605-009-1115-0","article-title":"Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2158 patients","volume":"14","author":"Franko","year":"2010","journal-title":"J Gastrointest Surg"},{"issue":"10","key":"10.1016\/j.semdp.2025.150946_bib0002","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/annonc\/mdn351","article-title":"Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival","volume":"19","author":"Halfdanarson","year":"2008","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.semdp.2025.150946_bib0003","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40618-022-01985-2","article-title":"The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States","volume":"46","author":"Liu","year":"2022","journal-title":"J Endocrinolog Investig"},{"issue":"4","key":"10.1016\/j.semdp.2025.150946_bib0004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: are There Global Differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"issue":"7","key":"10.1016\/j.semdp.2025.150946_bib0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/BF01297144","article-title":"Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases","volume":"36","author":"Kimura","year":"1991","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.semdp.2025.150946_bib0006","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/PAS.0b013e318263207c","article-title":"Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods","volume":"36","author":"Tang","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150946_bib0007","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/PAS.0b013e31821a0696","article-title":"Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification","volume":"35","author":"Yang","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150946_bib0008","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/modpathol.2014.156","article-title":"Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies","volume":"28","author":"Reid","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.semdp.2025.150946_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2024.152295","article-title":"Digital image analysis of Ki67 hotspot detection and index counting in gastroenteropancreatic neuroendocrine neoplasms","volume":"71","author":"Saetiew","year":"2024","journal-title":"Ann Diagn Pathol"},{"issue":"11","key":"10.1016\/j.semdp.2025.150946_bib0010","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/PAS.0000000000000089","article-title":"Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate","volume":"37","author":"McCall","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0011","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00535-014-0934-2","article-title":"Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis","volume":"50","author":"Ito","year":"2015","journal-title":"J Gastroenterol"},{"issue":"12","key":"10.1016\/j.semdp.2025.150946_bib0012","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1245\/s10434-007-9566-6","article-title":"Population-Based Study of Islet Cell Carcinoma","volume":"14","author":"Yao","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.semdp.2025.150946_bib0013","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0014","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","article-title":"Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study","volume":"24","author":"Sorbye","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150946_bib0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/PAS.0000000000000169","article-title":"Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases","volume":"38","author":"Basturk","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150946_bib0016","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","article-title":"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2025.150946_bib0017","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/pin.13105","article-title":"Mixed acinar-neuroendocrine carcinoma with amphicrine features of the pancreas: two rare cases with diffuse co-expression of acinar and neuroendocrine markers","volume":"71","author":"Akki","year":"2021","journal-title":"Pathol Int"},{"issue":"11","key":"10.1016\/j.semdp.2025.150946_bib0018","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.cgh.2018.12.017","article-title":"Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0019","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5543-2","article-title":"Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.semdp.2025.150946_bib0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.semdp.2025.150946_bib0021","article-title":"Charting the Course: insights into Neuroendocrine Tumor Dynamics in the United States","author":"Wu","year":"2024","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.semdp.2025.150946_bib0022","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/ERC-15-0119","article-title":"Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms","volume":"22","author":"Heetfeld","year":"2015","journal-title":"Endocrine-Relat Cancer"},{"issue":"5","key":"10.1016\/j.semdp.2025.150946_bib0023","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.pas.0000194044.01104.25","article-title":"Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome","volume":"30","author":"Anlauf","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150946_bib0024","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12022-014-9317-8","article-title":"Hyperplasia to neoplasia sequence of duodenal and pancreatic neuroendocrine diseases and pseudohyperplasia of the PP-cells in the pancreas","volume":"25","author":"Kloppel","year":"2014","journal-title":"Endocr Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150946_bib0025","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/1097-0142(19910915)68:6<1329::AID-CNCR2820680624>3.0.CO;2-7","article-title":"Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy","volume":"68","author":"Donow","year":"1991","journal-title":"Cancer,"},{"issue":"11","key":"10.1016\/j.semdp.2025.150946_bib0026","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the Duodenums of Patients with Multiple Endocrine Neoplasia Type 1 and the Zollinger-Ellison Syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0027","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAT.0b013e32835f45c5","article-title":"Precursor lesions of endocrine system neoplasms","volume":"45","author":"Mete","year":"2013","journal-title":"Pathology"},{"issue":"9","key":"10.1016\/j.semdp.2025.150946_bib0028","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0029","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPA.0b013e31815f394a","article-title":"Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features","volume":"37","author":"Corcos","year":"2008","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.semdp.2025.150946_bib0030","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-11-2759","article-title":"Molecular profiling of pancreatic neuroendocrine tumors in sporadic and von Hippel-Lindau patients","volume":"18","author":"Speisky","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.semdp.2025.150946_bib0031","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","article-title":"Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs)","volume":"142","author":"Blansfield","year":"2007","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.semdp.2025.150946_bib0032","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/ERC-18-0100","article-title":"Preventive medicine of von Hippel\u2013Lindau disease-associated pancreatic neuroendocrine tumors","volume":"25","author":"Krauss","year":"2018","journal-title":"Endocrine-Relat Cancer"},{"issue":"S7","key":"10.1016\/j.semdp.2025.150946_bib0033","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.semdp.2025.150946_bib0034","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40618-022-01905-4","article-title":"Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies","volume":"46","author":"Ruggeri","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jso.2930590116","article-title":"Von Recklinghausen's disease associated with duodenal somatostatinoma: contrast of duodenal versus pancreatic somatostatinomas","volume":"59","author":"Mao","year":"1995","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150946_bib0036","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0004.2011.01805.x","article-title":"Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex","volume":"82","author":"Larson","year":"2012","journal-title":"Clin Genet"},{"issue":"9","key":"10.1016\/j.semdp.2025.150946_bib0037","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1210\/jc.2018-01074","article-title":"Hypercalcemia in glucagon cell hyperplasia and neoplasia (Mahvash Syndrome): a new association","volume":"103","author":"Gild","year":"2018","journal-title":"J Clin Endocrinol Metabol"},{"issue":"8","key":"10.1016\/j.semdp.2025.150946_bib0038","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0032","article-title":"Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease","volume":"30","author":"Sipos","year":"2023","journal-title":"Endocrine-Relat Cancer"},{"issue":"5","key":"10.1016\/j.semdp.2025.150946_bib0039","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1073\/pnas.1712262115","article-title":"MAFA missense mutation causes familial insulinomatosis and diabetes mellitus","volume":"115","author":"Iacovazzo","year":"2018","journal-title":"Proceed Natl Acad Sci"},{"key":"10.1016\/j.semdp.2025.150946_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-642-83816-3_3","article-title":"Morphology and functional activity of gastroenteropancreatic neuroendocrine tumours","volume":"118","author":"Kloppel","year":"1990","journal-title":"Recent Result Cancer Res"},{"issue":"2","key":"10.1016\/j.semdp.2025.150946_bib0041","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0344-0338(88)80043-8","article-title":"Pancreatic endocrine tumors","volume":"183","author":"Kloppel","year":"1988","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0042","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/13506129.2021.1979512","article-title":"Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours","volume":"29","author":"Van Treeck","year":"2022","journal-title":"Amyloid"},{"issue":"S2","key":"10.1016\/j.semdp.2025.150946_bib0043","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1038\/modpathol.2010.127","article-title":"Pancreatic endocrine tumors","volume":"24","author":"Asa","year":"2011","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.semdp.2025.150946_bib0044","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1440-1827.2006.02042.x","article-title":"Oncocytic non-functioning endocrine tumor of the pancreas","volume":"56","author":"Sugihara","year":"2006","journal-title":"Pathol Int"},{"issue":"5","key":"10.1016\/j.semdp.2025.150946_bib0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00428-006-0154-0","article-title":"Clinico-pathological features of a series of 11 oncocytic endocrine tumours of the pancreas","volume":"448","author":"Volante","year":"2006","journal-title":"Virchow Arch"},{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0046","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12022-020-09628-z","article-title":"Morphologic variants of pancreatic neuroendocrine tumors: clinicopathologic analysis and prognostic stratification","volume":"31","author":"Xue","year":"2020","journal-title":"Endocrin Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0047","doi-asserted-by":"crossref","first-page":"W482","DOI":"10.2214\/AJR.10.5428","article-title":"Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction","volume":"197","author":"Kawamoto","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0048","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1148\/radiol.10100046","article-title":"Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production?","volume":"257","author":"Shi","year":"2010","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.semdp.2025.150946_bib0049","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.humpath.2011.09.014","article-title":"Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement","volume":"43","author":"McCall","year":"2012","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2025.150946_bib0050","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbadis.2012.09.009","article-title":"Serotonin paracrine signaling in tissue fibrosis","volume":"1832","author":"Mann","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.6409","article-title":"Should we worry about high-grade pancreatic neuroendocrine tumor progression and alkylating agents?","volume":"266","author":"Hackeng","year":"2025","journal-title":"J Pathol"},{"issue":"11","key":"10.1016\/j.semdp.2025.150946_bib0052","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/PAS.0b013e31826a0048","article-title":"Cystic pancreatic neuroendocrine tumors: a clinicopathologic study","volume":"36","author":"Singhi","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150946_bib0053","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2019.05.462","article-title":"Cystic pancreatic neuroendocrine tumors: a distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis","volume":"19","author":"Zhu","year":"2019","journal-title":"Pancreatology"},{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0054","doi-asserted-by":"crossref","first-page":"W283","DOI":"10.2214\/AJR.12.8941","article-title":"Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT","volume":"200","author":"Kawamoto","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11605-007-0219-7","article-title":"Pancreatic cystic neuroendocrine tumors: preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology","volume":"12","author":"Baker","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"9","key":"10.1016\/j.semdp.2025.150946_bib0056","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.pas.0000164370.81132.25","article-title":"Pleomorphic pancreatic endocrine neoplasms: a variant commonly confused with adenocarcinoma","volume":"29","author":"Zee","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.semdp.2025.150946_bib0057","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/PAS.0b013e31821a9a14","article-title":"Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis","volume":"35","author":"Meriden","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150946_bib0058","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.semdp.2014.08.010","article-title":"Diagnosis and molecular aspects of solid-pseudopapillary neoplasms of the pancreas","volume":"31","author":"Terris","year":"2014","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0059","first-page":"66","article-title":"Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential","volume":"17","author":"Klimstra","year":"2000","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150946_bib0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.semdp.2014.08.003","article-title":"Pathology and genetics of pancreatic neoplasms with acinar differentiation","volume":"31","author":"Wood","year":"2014","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150946_bib0061","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00428-008-0710-x","article-title":"The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia","volume":"454","author":"La Rosa","year":"2009","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.semdp.2025.150946_bib0062","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/his.12535","article-title":"Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour","volume":"66","author":"Johnson","year":"2015","journal-title":"Histopathology"},{"issue":"S1","key":"10.1016\/j.semdp.2025.150946_bib0063","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00292-024-01367-w","article-title":"Subtyping of pancreatic neuroendocrine tumors by transcription factors, hormones, histology, and patient outcome","volume":"45","author":"Moser","year":"2024","journal-title":"Die Patholog"},{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0064","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PAP.0000000000000256","article-title":"An algorithmic immunohistochemical approach to define tumor type and assign site of origin","volume":"27","author":"Bellizzi","year":"2020","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/his.13408","article-title":"Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases","volume":"72","author":"Singhi","year":"2018","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.semdp.2025.150946_bib0066","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/PAS.0000000000000662","article-title":"A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas","volume":"40","author":"Tang","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150946_bib0067","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100065","article-title":"Integrated genomic and clinicopathologic approach distinguishes pancreatic grade 3 neuroendocrine tumor from neuroendocrine carcinoma and identifies a subset with molecular overlap","volume":"36","author":"Umetsu","year":"2023","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0069","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-024-01546-6","article-title":"Navigating the diagnostic gray zone: a challenging case of pancreatic high-grade neuroendocrine neoplasm","volume":"19","author":"Mullen","year":"2024","journal-title":"Diagnostic Pathology"},{"key":"10.1016\/j.semdp.2025.150946_bib0070","doi-asserted-by":"crossref","DOI":"10.1093\/ajcp\/aqae184","article-title":"Diffuse expression of p16 in pancreatic neuroendocrine tumors (PanNETs) and the association of morphology variants","author":"Yablonski","year":"2025","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.semdp.2025.150946_bib0071","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/dc.25154","article-title":"Cytomorphologic observations on the sclerosing variant of well-differentiated pancreatic neuroendocrine tumors: towards making specific diagnoses early","volume":"51","author":"McKenzie","year":"2023","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0072","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jasc.2018.02.001","article-title":"Fine-needle aspiration-based grading of pancreatic neuroendocrine neoplasms using Ki-67: is accurate WHO grading possible on cytologic material?","volume":"7","author":"Weiss","year":"2018","journal-title":"J Am Soc Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150946_bib0073","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ajcp\/aqz110","article-title":"Grading pancreatic neuroendocrine tumors by Ki-67 index evaluated on fine-needle aspiration cell block material","volume":"153","author":"Abi-Raad","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150946_bib0074","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jasc.2016.03.002","article-title":"Grading pancreatic neuroendocrine neoplasms by Ki-67 staining on cytology cell blocks: manual count and digital image analysis of 58 cases","volume":"5","author":"Jin","year":"2016","journal-title":"J Am Soc Cytopathol"},{"issue":"7643","key":"10.1016\/j.semdp.2025.150946_bib0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"issue":"6021","key":"10.1016\/j.semdp.2025.150946_bib0076","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.semdp.2025.150946_bib0077","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1200\/JCO.2008.21.5988","article-title":"Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway","volume":"28","author":"Missiaglia","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150946_bib0078","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.semdp.2025.150946_bib0079","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","article-title":"Menin: a scaffold protein that controls gene expression and cell signaling","volume":"38","author":"Matkar","year":"2013","journal-title":"Trend Biochem Sci"},{"issue":"13","key":"10.1016\/j.semdp.2025.150946_bib0080","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1128\/MCB.24.13.5639-5649.2004","article-title":"Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression","volume":"24","author":"Yokoyama","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"32","key":"10.1016\/j.semdp.2025.150946_bib0081","doi-asserted-by":"crossref","first-page":"14075","DOI":"10.1073\/pnas.1008850107","article-title":"Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres","volume":"107","author":"Lewis","year":"2010","journal-title":"Proceed Natl Acad Sci"},{"issue":"6041","key":"10.1016\/j.semdp.2025.150946_bib0082","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered Telomeres in Tumors with ATRX and DAXX Mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.semdp.2025.150946_bib0083","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.semdp.2025.150946_bib0084","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/modpathol.2012.53","article-title":"Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors","volume":"25","author":"de Wilde","year":"2012","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150946_bib0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.CCR-16-1113","article-title":"Alternative lengthening of telomeres and loss of DAXX\/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine tumors","volume":"23","author":"Singhi","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.semdp.2025.150946_bib0086","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/1078-0432.CCR-16-1147","article-title":"Alternative lengthening of telomeres in primary pancreatic neuroendocrine tumors is associated with aggressive clinical behavior and poor survival","volume":"23","author":"Kim","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semdp.2025.150946_bib0087","article-title":"Prognostic significance of altered ATRX\/DAXX gene in pancreatic neuroendocrine tumors: a meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150946_bib0088","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/gutjnl-2020-322595","article-title":"Non-functional pancreatic neuroendocrine tumours: ATRX\/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX\/PDX1 expression and tumour size","volume":"71","author":"Hackeng","year":"2022","journal-title":"Gut"},{"issue":"23","key":"10.1016\/j.semdp.2025.150946_bib0089","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Gene Develop"},{"issue":"5","key":"10.1016\/j.semdp.2025.150946_bib0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","article-title":"Chk1 and Chk2 kinases in checkpoint control and cancer","volume":"3","author":"Bartek","year":"2003","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.semdp.2025.150946_bib0091","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/1940-6207.CAPR-23-0483","article-title":"Germline testing identifies pathogenic\/likely pathogenic variants in patients with pancreatic neuroendocrine tumors","volume":"17","author":"Mohindroo","year":"2024","journal-title":"Cancer Prevent Res"},{"issue":"3","key":"10.1016\/j.semdp.2025.150946_bib0092","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/2159-8290.CD-21-0669","article-title":"Comprehensive genomic profiling of neuroendocrine carcinomas of the gastrointestinal system","volume":"12","author":"Yachida","year":"2022","journal-title":"Cancer Discov"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257025000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257025000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:31:59Z","timestamp":1763469119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257025000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0740257025000826"],"URL":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150946","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic neuroendocrine neoplasms: current paradigms and diagnostic challenges","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150946"}}